Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Rob Owens

DocuSign Stock Jumps On Strong Q3, Analysts Await Proof Of Sustained Growth

DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.

Benzinga

Okta Posts Q3 Beat, Guidance Miss: Analyst Says 'Sustainable Growth Remains Hazy'

Okta Inc's shares rose after reporting Q3 results, despite concerns about competition and product expansion. Analysts have mixed opinions on the stock.

Benzinga

After Being Cut In Half, AI Stock SentinelOne Poised To Continue Its Advance

AI stock SentinelOne is trying to break out past its latest entry following a 53% plunge in its stock price, and a big subsequent rebound.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Analysts reboot CrowdStrike stock price targets after lawsuit

This is what could happen next to CrowdStrike shares.

The Street

Stock Market Today: Stocks Rise as Powell Praises Inflation Progress

Tesla was the best S&P 500 stock Tuesday after the EV maker disclosed its second-quarter deliveries report.

Kiplinger

CrowdStrike Stock Downgraded: Should Investors Be Worried?

The downgrade of CrowdStrike is a valuation call, Piper Sandler says. Here's what you need to know.

Kiplinger

Here's What Analysts Had To Say About GitLab Post Q1 Beat

Analysts acknowledged GitLab Inc's (NASDAQ:GTLB) Q1 beat by re-rating the stock. RBC Capital analyst Matthew Hedberg maintained GitLab with an Outperform and raised the price target from $64 to $66. GitLab reported a solid start to the year as execution continued in its third quarter as a public company, Hedberg noted. Revenue growth again accelerated while RPO…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.